-23.35% percent quarterly performance for Fate Therapeutics Inc (FATE) is not indicative of the underlying story
Fate Therapeutics Inc (NASDAQ: FATE) on Monday, soared 5.79% from the previous trading day, before settling in for the closing price of $2.42. Within the